|
US4690915A
(en)
|
1985-08-08 |
1987-09-01 |
The United States Of America As Represented By The Department Of Health And Human Services |
Adoptive immunotherapy as a treatment modality in humans
|
|
US5217891A
(en)
|
1987-07-28 |
1993-06-08 |
Chiron Corporation |
DNA constructs containing a kluyveromyces α factor leader sequence for directing secretion of heterologous polypeptides
|
|
WO1989012455A1
(en)
|
1988-06-15 |
1989-12-28 |
Whitehead Institute For Biomedical Research |
Stress proteins and uses therefor
|
|
WO1990002564A1
(en)
|
1988-09-12 |
1990-03-22 |
Codon |
Vaccine diagnostic employing proteins homologous to heat shock proteins of trypanosoma cruzi
|
|
US5232833A
(en)
|
1988-09-14 |
1993-08-03 |
Stressgen Biotechnologies Corporation |
Accumulation of heat shock proteins for evaluating biological damage due to chronic exposure of an organism to sublethal levels of pollutants
|
|
EP0484440A4
(en)
|
1989-07-28 |
1993-01-07 |
Us Health |
Efficient directional genetic cloning system
|
|
GB9007194D0
(en)
|
1990-03-30 |
1990-05-30 |
Wellcome Found |
Live vaccines
|
|
US5348945A
(en)
|
1990-04-06 |
1994-09-20 |
Wake Forest University |
Method of treatment with hsp70
|
|
US5188964A
(en)
|
1990-04-12 |
1993-02-23 |
Board Of Regents, The University Of Texas System |
Method and kit for the prognostication of breast cancer patient via heat shock/stress protein determination
|
|
GB9016315D0
(en)
|
1990-07-25 |
1990-09-12 |
Burnie James P |
Medicaments
|
|
CA2095855C
(en)
|
1990-11-08 |
2003-04-29 |
Graham A.W. Rook |
Mycobacterium as adjuvant for antigens
|
|
GB9024320D0
(en)
|
1990-11-08 |
1990-12-19 |
Univ London |
Treatment of uveitis
|
|
GB2251186A
(en)
|
1990-12-04 |
1992-07-01 |
Randall Neal Gatz |
Polypeptide for use in treatment of autoimmune disease
|
|
US5177942A
(en)
|
1991-08-15 |
1993-01-12 |
The Toro Company |
Mower deck with improved belt drive arrangement
|
|
GB9200949D0
(en)
|
1992-01-17 |
1992-03-11 |
Medical Res Council |
Diagnostic peptides
|
|
FR2688227A1
(fr)
|
1992-03-04 |
1993-09-10 |
Inst Nat Sante Rech Med |
Proteines formant des complexes avec des chaperones et leurs ligands, leurs fragments, leur obtention et leurs applications biologiques.
|
|
IT1262896B
(it)
|
1992-03-06 |
1996-07-22 |
|
Composti coniugati formati da proteine heat shock (hsp) e oligo-poli- saccaridi, loro uso per la produzione di vaccini.
|
|
CA2130089A1
(en)
|
1992-03-09 |
1993-09-16 |
Aldo Mancini |
Protein compound, coding nucleotide sequences, producing cell line and uses thereof
|
|
EP0636248A4
(en)
|
1992-04-14 |
1996-11-13 |
Univ Duke |
METHOD FOR DETECTING P53 AND HSP70 COMPLEX CONTAINING TUMORS.
|
|
JPH07509694A
(ja)
|
1992-05-14 |
1995-10-26 |
ベイラー・カレッジ・オブ・メディシン |
突然変異したステロイドホルモン受容体，その使用方法および遺伝子治療のための分子スイッチ
|
|
IL102687A
(en)
|
1992-07-30 |
1997-06-10 |
Yeda Res & Dev |
Conjugates of poorly immunogenic antigens and synthetic pepide carriers and vaccines comprising them
|
|
WO1994003599A1
(fr)
|
1992-08-04 |
1994-02-17 |
Sagami Chemical Research Center |
ADNc HUMAIN ET PROTEINE POUR LAQUELLE CODE CET ADNc
|
|
GB2270076A
(en)
|
1992-08-18 |
1994-03-02 |
Univ Manchester |
Human HSP 90 Epitopes
|
|
GB9223816D0
(en)
|
1992-11-13 |
1993-01-06 |
Medical Res Council |
Heat shock proteins and the treatment of tumours
|
|
HUT73383A
(en)
|
1993-03-19 |
1996-07-29 |
Boehringer Sohn Ingelheim |
Process for preparing cancer vaccines
|
|
US5496934A
(en)
|
1993-04-14 |
1996-03-05 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem |
Nucleic acids encoding a cellulose binding domain
|
|
US6004941A
(en)
|
1993-06-14 |
1999-12-21 |
Basf Aktiengesellschaft |
Methods for regulating gene expression
|
|
WO1995004824A1
(en)
|
1993-08-05 |
1995-02-16 |
Medvet Science Pty. Ltd. |
Generation of dna libraries and retroviral vectors for same
|
|
US5705159A
(en)
|
1993-08-31 |
1998-01-06 |
John Wayne Cancer Institute |
Immunoreactive peptide sequence from a 43 KD human cancer antigen
|
|
US5997873A
(en)
|
1994-01-13 |
1999-12-07 |
Mount Sinai School Of Medicine Of The City University Of New York |
Method of preparation of heat shock protein 70-peptide complexes
|
|
US5750119A
(en)
|
1994-01-13 |
1998-05-12 |
Mount Sinai School Of Medicine Of The City University Of New York |
Immunotherapeutic stress protein-peptide complexes against cancer
|
|
US5961979A
(en)
|
1994-03-16 |
1999-10-05 |
Mount Sinai School Of Medicine Of The City University Of New York |
Stress protein-peptide complexes as prophylactic and therapeutic vaccines against intracellular pathogens
|
|
DK0769932T3
(da)
|
1994-07-08 |
1999-06-23 |
Baxter Int |
Implanteret indretning indeholdende tumorceller til behandling af cancer
|
|
US5772995A
(en)
|
1994-07-18 |
1998-06-30 |
Sidney Kimmel Cancer Center |
Compositions and methods for enhanced tumor cell immunity in vivo
|
|
JP3907698B2
(ja)
|
1994-10-03 |
2007-04-18 |
アメリカ合衆国 |
抗原を発現する組み換えウイルスと免疫刺激分子を発現する組み換えウイルスとを含む組成物
|
|
US5703057A
(en)
|
1995-04-07 |
1997-12-30 |
Board Of Regents The University Of Texas System |
Expression library immunization
|
|
WO1997006821A1
(en)
|
1995-08-18 |
1997-02-27 |
Sloan-Kettering Institute For Cancer Research |
Heat shock protein-based vaccines and immunotherapies
|
|
US6719974B1
(en)
|
1995-08-18 |
2004-04-13 |
Sloan-Kettering Institute For Cancer Research |
Heat shock protein-based vaccines and immunotherapies
|
|
US6331299B1
(en)
|
1995-08-18 |
2001-12-18 |
Sloan-Kettering Institute For Cancer Research |
Method for treatment of cancer and infectious disease and compositions useful in same
|
|
US6761892B1
(en)
|
1995-08-18 |
2004-07-13 |
Sloan-Kettering Institute For Cancer Research |
Heat shock protein-based vaccines and immunotherapies
|
|
US5837251A
(en)
|
1995-09-13 |
1998-11-17 |
Fordham University |
Compositions and methods using complexes of heat shock proteins and antigenic molecules for the treatment and prevention of neoplastic diseases
|
|
US5935576A
(en)
|
1995-09-13 |
1999-08-10 |
Fordham University |
Compositions and methods for the treatment and prevention of neoplastic diseases using heat shock proteins complexed with exogenous antigens
|
|
WO1997010000A1
(en)
|
1995-09-13 |
1997-03-20 |
Fordham University |
Therapeutic and prophylactic methods using heat shock proteins
|
|
US5985270A
(en)
|
1995-09-13 |
1999-11-16 |
Fordham University |
Adoptive immunotherapy using macrophages sensitized with heat shock protein-epitope complexes
|
|
DE19602985A1
(de)
|
1996-01-27 |
1997-07-31 |
Max Delbrueck Centrum |
Tumorzellimpfstoff für die Immuntheraphie von malignen Tumoren
|
|
WO1997026910A2
(de)
|
1996-01-27 |
1997-07-31 |
Max-Delbrück-Centrum für Molekulare Medizin |
Tumorimpfstoff für die immuntherapie von malignen tumoren
|
|
US5951976A
(en)
|
1996-03-28 |
1999-09-14 |
Whitenead Institute For Biomedical Research |
Opsonin-enhanced cells, and methods of modulating an immune response to an antigen
|
|
US5747332A
(en)
|
1996-09-20 |
1998-05-05 |
University Of New Mexico |
Methods for purifying and synthesizing heat shock protein complexes
|
|
US6130087A
(en)
|
1996-10-07 |
2000-10-10 |
Fordham University |
Methods for generating cytotoxic T cells in vitro
|
|
JP4484969B2
(ja)
|
1996-11-26 |
2010-06-16 |
ヌベンタ バイオファーマスティカル コーポレイション |
ストレスタンパク質を含む組成物を使用する免疫応答
|
|
US5830464A
(en)
|
1997-02-07 |
1998-11-03 |
Fordham University |
Compositions and methods for the treatment and growth inhibition of cancer using heat shock/stress protein-peptide complexes in combination with adoptive immunotherapy
|
|
US6017540A
(en)
|
1997-02-07 |
2000-01-25 |
Fordham University |
Prevention and treatment of primary and metastatic neoplastic diseases and infectious diseases with heat shock/stress protein-peptide complexes
|
|
US6015709A
(en)
|
1997-08-26 |
2000-01-18 |
Ariad Pharmaceuticals, Inc. |
Transcriptional activators, and compositions and uses related thereto
|
|
US6007821A
(en)
|
1997-10-16 |
1999-12-28 |
Fordham University |
Method and compositions for the treatment of autoimmune disease using heat shock proteins
|
|
US5948646A
(en)
|
1997-12-11 |
1999-09-07 |
Fordham University |
Methods for preparation of vaccines against cancer comprising heat shock protein-peptide complexes
|
|
JP4768122B2
(ja)
|
1998-02-20 |
2011-09-07 |
ユニバーシティー オブ マイアミ |
改変型熱ショックタンパク質−抗原性ペプチド複合体
|
|
US5989910A
(en)
|
1998-08-03 |
1999-11-23 |
University Of Lausanne |
Potent genetic switch allowing regulated gene expression in eukaryotic cells
|
|
US6797480B1
(en)
|
1998-10-05 |
2004-09-28 |
University Of Connecticut Health Center |
Purification of heat shock/stress protein cell surface receptors and their use as immunotherapeutic agents
|
|
US6451316B1
(en)
|
1998-10-05 |
2002-09-17 |
University Of Conneticut Health Center |
Methods for generating antigen-reactive T cells in vitro
|
|
US6475490B1
(en)
|
1998-10-19 |
2002-11-05 |
Fordham University |
Compositions and methods for promoting tissue repair using heat shock proteins
|
|
US6734172B2
(en)
*
|
1998-11-18 |
2004-05-11 |
Pacific Northwest Research Institute |
Surface receptor antigen vaccines
|
|
DK1149114T3
(da)
*
|
1999-02-03 |
2014-06-23 |
Amgen Inc |
Polypeptider, der er involveret ved et immunrespons
|
|
CN1688695B
(zh)
*
|
2000-04-28 |
2011-05-11 |
约翰霍普金斯大学 |
新的树突状细胞共刺激分子
|
|
US7132109B1
(en)
|
2000-10-20 |
2006-11-07 |
University Of Connecticut Health Center |
Using heat shock proteins to increase immune response
|
|
US20030044386A1
(en)
|
2001-07-11 |
2003-03-06 |
Barber Glen N. |
Recombinant VSV for the treatment of tumor cells
|
|
HK1079705A1
(zh)
*
|
2001-08-20 |
2006-04-13 |
University Of Connecticut Health Center |
包含用於治疗癌症及感染性疾病的热休克蛋白或α2-巨球蛋白的组合物制备方法
|
|
AU2002364935A1
(en)
*
|
2001-10-09 |
2003-06-23 |
Mayo Foundation For Medical Education And Research |
Enhancement of immune responses by 4-1bb-binding agents
|
|
EP1456376A4
(en)
|
2001-11-16 |
2006-09-06 |
Us Gov Health & Human Serv |
NEW CHIMERAL REV, TAT AND NEF ANTIGENES
|
|
WO2003057171A2
(en)
*
|
2002-01-03 |
2003-07-17 |
The Trustees Of The University Of Pennsylvania |
Activation and expansion of t-cells using an engineered multivalent signaling platform
|
|
US20030170756A1
(en)
|
2002-02-01 |
2003-09-11 |
Thomas Jefferson University |
Treatment of tumor cells for use in immunotherapy of cancer
|
|
CN1440812A
(zh)
*
|
2002-02-27 |
2003-09-10 |
上海中信国健药业有限公司 |
一种使用cd137结合激动剂增强免疫应答的方法
|
|
CA2477417A1
(en)
*
|
2002-02-28 |
2003-09-04 |
Antigenics Inc. |
Methods and products based on oligomerization of stress proteins
|
|
IL164376A0
(en)
*
|
2002-04-03 |
2005-12-18 |
Applied Research Systems |
Ox4or binding agents, their preparation and pharmaceutical compositions containing them
|
|
WO2003090686A2
(en)
*
|
2002-04-25 |
2003-11-06 |
University Of Connecticut Health Center |
Using heat shock proteins to improve the therapeutic benefit of a non-vaccine treatment modality
|
|
US6984389B2
(en)
*
|
2002-04-25 |
2006-01-10 |
University Of Connecticut Health Center |
Using heat shock proteins to improve the therapeutic benefit of a non-vaccine treatment modality
|
|
CA2489004C
(en)
*
|
2002-06-13 |
2013-01-08 |
Crucell Holland B.V. |
Agonistic binding molecules to the human ox40 receptor
|
|
DK1549353T3
(da)
|
2002-10-09 |
2010-07-12 |
Central Iowa Health System |
Anvendelse af alfa(1,3)galactosyltransferaseudtrykkende allogene tumorceller til vaccination mod tumorer
|
|
US20040197312A1
(en)
*
|
2003-04-02 |
2004-10-07 |
Marina Moskalenko |
Cytokine-expressing cellular vaccine combinations
|
|
JP2007505147A
(ja)
*
|
2003-09-12 |
2007-03-08 |
アンティジェニクス インコーポレーテッド |
単純ヘルペスウイルス感染の治療および予防用ワクチン
|
|
EP1667701A4
(en)
|
2003-09-26 |
2007-02-14 |
Univ Miami |
TUMOR VACCINE
|
|
WO2005030963A1
(en)
|
2003-09-26 |
2005-04-07 |
Applied Research Systems Ars Holding N.V. |
Leader sequences for use in production of proteins
|
|
CA2548347A1
(en)
*
|
2003-12-11 |
2005-06-30 |
Sidney Kimmel Cancer Center |
Methods for generating immunity to antigen
|
|
FR2867982B1
(fr)
|
2004-03-26 |
2007-07-20 |
Jean Marie Andrieu |
Procede pour amplifier l'activite de vaccins therapeutiques
|
|
WO2005124346A1
(en)
*
|
2004-05-17 |
2005-12-29 |
The Board Of Trustees Of The University Of Illinois |
4-1bb receptors are expressed on regulatory t-cells
|
|
WO2006123256A2
(en)
|
2005-02-24 |
2006-11-23 |
Medical Research Council |
Hivcon: an hiv immunogen and uses thereof
|
|
DK2650020T3
(en)
*
|
2005-05-06 |
2017-01-16 |
Providence Health & Services - Oregon |
Trimeric OX40 immunoglobulin fusion protein and methods for applications.
|
|
JP5164167B2
(ja)
*
|
2005-08-30 |
2013-03-13 |
ユニバーシティー オブ マイアミ |
免疫調節性腫瘍壊死因子受容体２５（ｔｎｆｒ２５）のアゴニスト、アンタゴニスト及び免疫毒素
|
|
WO2007130493A2
(en)
*
|
2006-05-03 |
2007-11-15 |
Regents Of The University Of Colorado |
Cd40 agonist antibody/type1 interferon synergistic adjuvant combination, conjugates containing and use thereof as a therapeutic to enhance cellular immunity
|
|
US20100247562A1
(en)
*
|
2006-08-24 |
2010-09-30 |
Trustees Of Boston University |
Complexes Derived from Heterohybrid Cells and Uses Thereof
|
|
CA2682527C
(en)
*
|
2007-03-30 |
2017-07-11 |
Memorial Sloan-Kettering Cancer Center |
Constitutive expression of costimulatory ligands on adoptively transferred t lymphocytes
|
|
ITPD20070252A1
(it)
*
|
2007-07-24 |
2009-01-25 |
Primiero Paolo |
Complessi di grp94 ed immunoglobuline g umane
|
|
US9408909B2
(en)
*
|
2007-09-14 |
2016-08-09 |
Vrije Universiteit Brussel |
Enhancing the T-cell stimulatory capacity of human antigen presenting cells in vitro and in vivo and its use in vaccination
|
|
GB0719509D0
(en)
*
|
2007-10-05 |
2007-11-14 |
Isis Innovation |
Molecular adjuvant
|
|
DK2257301T3
(da)
|
2008-03-03 |
2014-04-28 |
Univ Miami |
Immunterapi baseret på allogene cancerceller.
|
|
WO2009114110A1
(en)
*
|
2008-03-08 |
2009-09-17 |
Immungene, Inc. |
Engineered fusion molecules immunotherapy in cancer and inflammatory diseases
|
|
KR20110017356A
(ko)
|
2008-03-20 |
2011-02-21 |
유니버시티 오브 마이애미 |
열충격 단백질 ｇｐ96 백신접종 및 이를 사용하는 방법
|
|
US9931386B2
(en)
*
|
2008-06-16 |
2018-04-03 |
Atsuo Ochi |
Recombinant multiple domain fusion protein mitogens and use thereof for inducing enhancement or repression of antigen-specific immunity
|
|
CN102223894A
(zh)
|
2008-11-21 |
2011-10-19 |
迈阿密大学 |
用于产生粘膜和系统免疫的hiv/siv疫苗
|
|
AU2009333580B2
(en)
|
2008-12-09 |
2016-07-07 |
Genentech, Inc. |
Anti-PD-L1 antibodies and their use to enhance T-cell function
|
|
AU2010232490B2
(en)
*
|
2009-04-03 |
2016-08-11 |
Agenus Inc. |
Methods for preparing and using multichaperone-antigen complexes
|
|
ES2666152T3
(es)
*
|
2009-08-13 |
2018-05-03 |
The Johns Hopkins University |
Métodos de modulación de la función inmunitaria con anticuerpos anti-B7-H7CR
|
|
US9459246B2
(en)
|
2009-09-08 |
2016-10-04 |
Nodality, Inc. |
Induced intercellular communication
|
|
EP3375791A1
(en)
*
|
2009-09-30 |
2018-09-19 |
Memorial Sloan Kettering Cancer Center |
Combination immunotherapy for the treatment of cancer
|
|
WO2011069529A1
(en)
|
2009-12-09 |
2011-06-16 |
Curevac Gmbh |
Mannose-containing solution for lyophilization, transfection and/or injection of nucleic acids
|
|
CA2794196A1
(en)
*
|
2010-03-23 |
2011-09-29 |
Intrexon Corporation |
Vectors conditionally expressing therapeutic proteins, host cells comprising the vectors, and uses thereof
|
|
WO2011131472A1
(en)
|
2010-04-22 |
2011-10-27 |
Institut Gustave Roussy |
Compounds and uses thereof to induce an immunogenic cancer cell death in a subject
|
|
WO2011146395A2
(en)
*
|
2010-05-17 |
2011-11-24 |
The Board Of Trustees Of The Leland Stanford Junior University |
Prevention of immunological rejection of transplanted stem cells by leukocyte costimulatory molecule blockade
|
|
EP2571522A4
(en)
*
|
2010-05-21 |
2013-11-20 |
Univ Miami |
CANCER TREATMENT
|
|
US9234042B2
(en)
*
|
2010-10-18 |
2016-01-12 |
Delphi Genetics Sa |
Method for producing antibody using “naked” expression vector expressing type II transmembrane fusion protein
|
|
CN102462841A
(zh)
*
|
2010-11-09 |
2012-05-23 |
中国科学院微生物研究所 |
一种促进gp96蛋白的免疫活性的方法及其应用
|
|
EP2678031A4
(en)
|
2011-02-23 |
2015-09-02 |
Univ Miami |
COMBINED VACCINATION WITH CELL-BASED GP96-IG-SIV / HIV AND THE RECOMBINANT PROTEIN GP120 FOR PROTECTION AGAINST SIV / HIV
|
|
EP2714081A4
(en)
|
2011-05-27 |
2015-09-09 |
Cytocure Llc |
METHODS, COMPOSITIONS AND KIT FOR CREAM TREATMENT
|
|
CN104769104A
(zh)
*
|
2011-12-12 |
2015-07-08 |
细胞药物有限公司 |
扩大t细胞的方法
|
|
EP3466443B1
(en)
*
|
2012-02-14 |
2020-12-16 |
Boehringer Ingelheim Animal Health USA Inc. |
Recombinant poxviral vectors expressing both rabies and ox40 proteins, and vaccines made therefrom
|
|
CN104968364A
(zh)
*
|
2012-12-03 |
2015-10-07 |
百时美施贵宝公司 |
强化免疫调变性Fc融合蛋白的抗癌活性
|
|
EA201591153A1
(ru)
*
|
2013-01-02 |
2016-01-29 |
Гленмарк Фармасьютикалс С.А. |
Антитела, связывающиеся с tl1a, и их применение
|
|
WO2014110258A1
(en)
*
|
2013-01-09 |
2014-07-17 |
Podack Eckhard R |
Compositions and methods for the regulation of t regulatory cells using tl1a-ig fusion protein
|
|
US10533054B2
(en)
*
|
2013-01-31 |
2020-01-14 |
Thomas Jefferson University |
Agonist fusion protein for CD40 and OX40 and methods of stimulating the immune system
|
|
JP6518199B6
(ja)
|
2013-03-15 |
2019-06-12 |
ノヴェロジックス・バイオテクノロジー，インコーポレーテッド |
Ｍｉｃａおよびｍｉｃｂタンパク質に対する抗体
|
|
US20160030659A1
(en)
|
2013-03-15 |
2016-02-04 |
Novelogics Biotechnology, Inc. |
Methods and devices for removal of immunosuppressive ligands
|
|
US10196435B2
(en)
*
|
2013-11-18 |
2019-02-05 |
University Of Southern California |
OX40L fusion protein for the immunotherapy of tumors of veterinary animals
|
|
CA2931322A1
(en)
*
|
2013-11-22 |
2015-05-28 |
Dnatrix, Inc. |
Adenovirus expressing immune cell stimulatory receptor agonist(s)
|
|
EP3082853A2
(en)
*
|
2013-12-20 |
2016-10-26 |
The Broad Institute, Inc. |
Combination therapy with neoantigen vaccine
|
|
WO2015131176A1
(en)
*
|
2014-02-28 |
2015-09-03 |
Podack Eckhard R |
Compositions, methods, and kits for treatment of cancer
|
|
CN106457001B
(zh)
*
|
2014-04-03 |
2021-02-02 |
奥古斯特大学研究学院公司 |
用于增强针对肿瘤的免疫应答的效力的方法
|
|
RU2016150096A
(ru)
*
|
2014-05-29 |
2018-07-02 |
МЕДИММЬЮН, ЭлЭлСи |
Белки слияния на основе ox40l и пути их применения
|
|
MA41414A
(fr)
*
|
2015-01-28 |
2017-12-05 |
Centre Nat Rech Scient |
Protéines de liaison agonistes d' icos
|
|
MA41460A
(fr)
*
|
2015-02-03 |
2017-12-12 |
Oncomed Pharm Inc |
Agents de liaison à la tnfrsf et leurs utilisations
|
|
BR112017016681A2
(pt)
*
|
2015-02-06 |
2018-04-10 |
Heat Biologics Inc |
vetor de coexpressão de vacina e moléculas coestimulatórias
|
|
CA2984794A1
(en)
*
|
2015-05-07 |
2016-11-10 |
Agenus Inc. |
Anti-ox40 antibodies and methods of use thereof
|
|
KR102423942B1
(ko)
*
|
2016-06-09 |
2022-07-22 |
펠리칸 테라퓨틱스, 인코포레이티드 |
항-tnfrsf25 항체
|
|
CA3058938A1
(en)
*
|
2017-04-04 |
2018-10-11 |
Heat Biologics, Inc. |
Intratumoral vaccination
|
|
AU2018373390A1
(en)
*
|
2017-11-27 |
2020-05-21 |
Heat Biologics, Inc. |
Gp96-based cancer therapy
|
|
WO2020072395A1
(en)
*
|
2018-10-01 |
2020-04-09 |
Heat Biologics, Inc. |
Combination cell-based therapies
|
|
US20220289838A1
(en)
*
|
2019-08-19 |
2022-09-15 |
Nantong Yichen Biopharma. Co. Ltd. |
Immunocytokine, Preparation for the Same, and Uses Thereof
|
|
WO2021178416A1
(en)
*
|
2020-03-02 |
2021-09-10 |
Heat Biologics, Inc. |
Immune-mediated coronavirus treatments
|